Community Health Worker Program for Colorectal Cancer and Cardiovascular Disease
(CHURCH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new community-based program to prevent colorectal cancer (CRC) and reduce heart disease risks. It includes two main components: SBIRT (Screening, Brief Intervention, and Referral to Treatment) for early CRC screening and treatment, and a lifestyle program called "Alive!" that promotes healthier living to lower heart disease risks linked to CRC. Participants will either receive usual referral information or participate in the SBIRT program and the "Alive!" lifestyle guide. Ideal candidates are English-speaking individuals aged 45 and older who haven't had a recent CRC screening.
As an unphased trial, this study provides a unique opportunity to contribute to innovative prevention strategies for CRC and heart disease.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on lifestyle changes and community health worker support.
What prior data suggests that this program is safe for participants?
Research has shown that the SBIRT approach used in this trial is generally safe. SBIRT stands for Screening, Brief Intervention, and Referral to Treatment. Initially developed for individuals at risk of mental health issues, this method has been tested and is considered safe and effective for promoting behavior change. It employs motivational interviewing to encourage positive changes, which participants have found manageable.
The Alive! program, included in this trial, is an online lifestyle coaching tool designed to enhance physical activity and eating habits. This program poses low risk as it provides guidance and support for healthier living.
Both components of the trial aim to improve health through education and motivation. Studies reviewed have not identified any specific negative effects or safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about the SBIRT approach for addressing colorectal cancer and cardiovascular disease because it's a novel way of combining behavioral health strategies with lifestyle coaching. Unlike traditional approaches that might focus solely on medical treatments or surgery, SBIRT integrates Screening, Brief Intervention, and Referral to Treatment with Motivational Interviewing to boost lifestyle changes. Additionally, the culturally-adapted Alive! Program offers a personalized, web-based platform to coach individuals on physical activity, eating habits, and weight control, making the intervention more accessible and tailored to individual needs. This dual focus on behavior change and lifestyle improvements sets it apart from standard care options, potentially leading to more sustainable health outcomes.
What evidence suggests that this trial's treatments could be effective for colorectal cancer and cardiovascular disease?
Research has shown that SBIRT (Screening, Brief Intervention, and Referral to Treatment) increases the number of people screened for health issues like colorectal cancer. It employs motivational interviewing, a method that encourages health changes by addressing mixed feelings. Studies have found that SBIRT effectively connects people to necessary treatments. In this trial, participants in the SBIRT arm will also receive a culturally-adapted online program called Alive!, which helps improve lifestyle habits like diet and exercise. Initial evidence suggests that combining these methods can lower risk factors for both colorectal cancer and heart disease. Meanwhile, participants in the Referral as Usual (RAU) arm will receive standard educational materials and contact information for screening services.12367
Who Is on the Research Team?
Olajide A. Williams, MD, MS
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for English-speaking Black individuals aged 45 and older who are not current with colorectal cancer (CRC) screenings, have a working telephone, and can provide informed consent. There are no specific exclusion criteria listed.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the SBIRT intervention, including Screening, Brief Intervention, and Referral to Treatment, along with the culturally-adapted Alive! program for lifestyle coaching.
Follow-up
Participants are monitored for CRC screening uptake and changes in dietary and cardiovascular health scores.
What Are the Treatments Tested in This Trial?
Interventions
- Referral as Usual (RAU)
- SBIRT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator